Verbatim response from ChatGPT
Short answer: pick a telehealth service that uses a licensed, experienced prescriber (preferably an obesity-medicine or endocrinology clinician), does a proper medical evaluation and labs, provides clear monitoring and follow‑up, uses a verified pharmacy (brand Wegovy or FDA‑approved product), and is transparent about total cost, shipping and refund/cancellation policies.
Checklist — what to look for and why
-
Clinician credentials and licensing
- Board certification, state medical license, and experience treating obesity (ABOM — American Board of Obesity Medicine — certification is a strong plus).
- Why: GLP‑1 prescribing needs medical judgment about dosing, side effects and contraindications.
-
Thorough initial evaluation
- Medical history, current meds, family history (thyroid cancer, MEN2), pregnancy risk, check for pancreatitis history, baseline weight/BMI and goals.
- Why: to identify contraindications and drug interactions (e.g., insulin or sulfonylureas).
-
Baseline tests and ongoing monitoring
- Ask if they order labs (A1c, kidney function, pregnancy test if applicable, lipid panel) when appropriate, and how often they’ll reassess.
- Why: safety and to measure progress.
-
Clear dosing/titration plan and side‑effect counseling
- A documented titration schedule, guidance for nausea/hypoglycemia, and instructions for missed doses.
- Why: proper titration reduces side effects and improves adherence.
-
Follow‑up and access
- Frequency of follow‑ups, how easy it is to message the care team, response times, and who to contact for urgent issues.
- Why: GLP‑1 therapy needs follow‑up, especially early on.
-
Pharmacy, medication source and shipping
- Will they prescribe brand Wegovy (Novo Nordisk) or generic/compounded semaglutide? Use a verified specialty or national pharmacy, shipped with cold‑chain handling.
- Why: compounded products vary in quality; counterfeit or improperly shipped injectable meds are dangerous.
-
Cost transparency and insurance help
- Total cost (visit fees + med price + shipping + labs), billing model (one‑time vs monthly subscription), whether they assist with prior authorization or coupons.
- Why: many insurers require prior authorization; out‑of‑pocket costs vary widely.
-
Safety policies and documentation
- Informed consent, privacy/HIPAA standards on the telehealth platform, cancellation/refund policy.
- Why: protects you legally and financially.
Red flags — what to avoid
- Prescription given immediately with no medical history, vitals or labs.
- No prescriber name, credentials or state license listed.
- Only offering compounded semaglutide or unspecified “generics” without pharmacy verification.
- Promises of a fixed large percentage weight loss or “guaranteed” results.
- Hidden fees revealed only after payment or very limited/no follow‑up included.
Questions to ask before you pay
- Are you licensed to prescribe in my state? Can I see the prescriber’s name and credentials?
- Will you review my medical history and order baseline labs? Which labs?
- Do you prescribe brand Wegovy or compounded/generic semaglutide? Which pharmacy do you use?
- What is the full cost (visits, meds, shipping, labs) and refund/cancellation policy?
- How often will I have follow‑ups and how do I reach the clinician between visits?
- Do you handle prior authorizations or provide savings program assistance?
Where to find reputable providers
- Look for ABOM‑certified obesity medicine physicians (search “ABOM directory” or “find an obesity medicine provider”).
- Large, established telehealth platforms that also provide specialty care and have transparent processes — examples to check (confirm current offerings): One Medical, Teladoc/ApolloMD, Amwell, PlushCare, and major health systems that offer tele‑visits. Verify they explicitly offer Wegovy and review their policies.
- Local endocrinologists or obesity clinics that offer telehealth (often best for complex medical histories).
If you have specific providers in mind, tell me their names and I can help you evaluate them against these criteria.